These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35183572)

  • 1. Comparison of gene fusion detection methods in salivary gland tumors.
    Sun L; Petrone JS; McNulty SN; Evenson MJ; Zhu X; Robinson JA; Chernock RD; Duncavage EJ; Pfeifer JD
    Hum Pathol; 2022 May; 123():1-10. PubMed ID: 35183572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors.
    Bubola J; MacMillan CM; Demicco EG; Chami RA; Chung CT; Leong I; Marrano P; Onkal Z; Swanson D; Veremis BM; Weinreb I; Zhang L; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2021 Oct; 60(10):695-708. PubMed ID: 34176176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
    Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
    Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
    Hung YP; Jo VY; Hornick JL
    Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SS18 Break-Apart Fluorescence In Situ Hybridization is a Practical and Effective Method for Diagnosing Microsecretory Adenocarcinoma of Salivary Glands.
    Bishop JA; Koduru P; Veremis BM; Oliai BR; Weinreb I; Rooper LM; Dickson BC; Demicco EG
    Head Neck Pathol; 2021 Sep; 15(3):723-726. PubMed ID: 33394377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of salivary gland and sinonasal fusions by a next-generation sequencing based, ligation-dependent, multiplex RT-PCR assay.
    Lanic MD; Guérin R; Wassef M; Durdilly P; Rainville V; Sater V; Jardin F; Ruminy P; Costes-Martineau V; Laé M
    Histopathology; 2023 Nov; 83(5):685-699. PubMed ID: 37350081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving role of molecular pathology in the diagnosis of salivary gland tumours with potential pitfalls.
    Kaur K; Mehta S; Vanik S; Trivedi P; Banerjee N; Dhar H; Datta S; Karanjai S
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3769-3783. PubMed ID: 35267084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of fluorescence in situ hybridization testing on cytology cell blocks for the definitive classification of salivary gland neoplasms.
    Darras N; Mooney KL; Long SR
    J Am Soc Cytopathol; 2019; 8(3):157-164. PubMed ID: 31097292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
    Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
    Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].
    Fehr A; Stenman G; Bullerdiek J; Löning T
    Pathologe; 2009 Nov; 30(6):466-71. PubMed ID: 19784654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRTC1-MAML2 and CRTC3-MAML2 fusions were not detected in metaplastic Warthin tumor and metaplastic pleomorphic adenoma of salivary glands.
    Skálová A; Vanecek T; Simpson RH; Vazmitsel MA; Majewska H; Mukensnabl P; Hauer L; Andrle P; Hosticka L; Grossmann P; Michal M
    Am J Surg Pathol; 2013 Nov; 37(11):1743-50. PubMed ID: 24121173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic Salivary Gland Neoplasms: Diagnostic Approach With a Focus on Ancillary Studies.
    Ribeiro EA; Maleki Z
    Adv Anat Pathol; 2022 Nov; 29(6):365-372. PubMed ID: 36044380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytopathologic features of mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista DA; Westra WH; Ali SZ
    Cancer Cytopathol; 2013 May; 121(5):228-33. PubMed ID: 23042752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I
    Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of fluorescent in-situ hybridisation in salivary gland cytology: A powerful diagnostic tool.
    Evrard SM; Meilleroux J; Daniel G; Basset C; Lacoste-Collin L; Vergez S; Uro-Coste E; Courtade-Saidi M
    Cytopathology; 2017 Aug; 28(4):312-320. PubMed ID: 28503786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.
    Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR
    Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.
    Asahina M; Saito T; Hayashi T; Fukumura Y; Mitani K; Yao T
    Histopathology; 2019 Feb; 74(3):514-525. PubMed ID: 30307055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYB gene abnormalities t(6;9) in adenoid cystic carcinoma fine-needle aspiration biopsy using fluorescence in situ hybridization.
    Hudson JB; Collins BT
    Arch Pathol Lab Med; 2014 Mar; 138(3):403-9. PubMed ID: 24576033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
    Stenman G
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.